Skip to Main Content

Paper Details

DNMT3A co-mutation is required for FLT3-ITD as an adverse prognostic indicator in intermediate-risk cytogenetic group AML.
Leuk Lymphoma
10
2018
Author NameAffiliation
Jennifer DunlapOregon Health & Science University
Elie TraerKnight Cancer Institute , Oregon Health & Science University
Richard D PressOregon Health & Science University
Guang FanOregon Health & Science University
  • 1 - 4

Datasets

Release 1.2